Saizen

Saizen is a commercial preparation of synthetic Human Growth Hormone (HGH), also known as somatropin. It is produced by Merck Serono, a division of the global pharmaceutical company Merck KGaA. Saizen is used in the treatment of growth hormone deficiency in both children and adults.

History

Saizen was approved by the Food and Drug Administration (FDA) in the United States in 1996. It was one of the first synthetic growth hormones to be approved for use in treating growth hormone deficiency.

Medical Uses

Saizen is used to treat Growth Hormone Deficiency in both children and adults. In children, this can result in short stature and delayed growth. In adults, growth hormone deficiency can cause a variety of symptoms, including decreased muscle and bone mass, increased body fat, and fatigue.

Administration

Saizen is administered through subcutaneous injection. The dosage is determined by the prescribing physician, based on the patient's weight and the severity of their growth hormone deficiency.

Side Effects

Like all medications, Saizen can cause side effects. These can include joint pain, muscle pain, and swelling at the injection site. More serious side effects can include changes in vision, increased thirst and urination, and severe stomach pain.

See Also

• Growth Hormone Therapy
• Growth Hormone Deficiency
• Merck KGaA

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian